Long-term study links higher weekly activity to slower Parkinson's progression

Key points

• A cohort study of 294 patients found that higher weekly physical activity was linked to slower cognitive and motor decline over up to seven years.
• Patients active for more than eight hours per week showed the greatest benefits, but those active for at least four hours also outperformed less active groups.
• Total activity time was more strongly associated with outcomes than exercise intensity, with vigorous activity showing no additional benefit beyond total time.
• Researchers emphasize that the observational design cannot prove causation, as slower disease progression may enable greater activity rather than the reverse.
• The findings add to limited evidence on long-term exercise benefits, as previous randomized trials were limited to short-term motor outcomes.

Background

Previous randomized trials, such as Park-in-Shape and SPARX, demonstrated short-term motor benefits from exercise in Parkinson's patients but lacked long-term data due to ethical and practical challenges in maintaining inactive control groups. A 2022 study also linked regular exercise to slower cognitive decline in early Parkinson's, but the current study provides a longer-term perspective on both motor and cognitive trajectories.

How outlets are covering it

Medscape and Brain and Life Magazine emphasize the dual benefits of activity on both motor and cognitive functions, highlighting the importance of duration over intensity. The Washington Post frames the findings as a potential answer to the debate over exercise intensity versus duration. Experts like Daniel Corcos caution that self-reported activity data may be inaccurate and that the results may not be universal, while Bastiaan Bloem supports the biological plausibility of exercise's neuroprotective effects. KRCG focuses on the broader quality-of-life benefits of exercise for Parkinson's patients, though its content was largely inaccessible in the provided source.

Why it matters

This study offers crucial long-term evidence that physical activity may slow the progression of Parkinson's disease, a condition with no proven disease-modifying drug. Understanding the relationship between activity duration and disease progression could inform clinical guidelines and patient recommendations, potentially improving quality of life and delaying functional decline. However, the observational nature of the study means that causation cannot be established, and further randomized trials are needed to confirm these findings and determine optimal exercise prescriptions.

What to watch

Researchers plan to analyze the relationship between physical activity and disease-related biomarkers, such as alpha-synuclein, amyloid-beta, and tau in cerebrospinal fluid, to clarify whether the benefits are disease-specific. Additionally, ongoing trials like SPARX3 will compare high- and moderate-intensity exercise to further understand the role of intensity in Parkinson's management.